BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24953501)

  • 1. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
    Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
    Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
    Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
    Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synaptic recruitment of lipid rafts is dependent on CD19-PI3K module and cytoskeleton remodeling molecules.
    Xu L; Auzins A; Sun X; Xu Y; Harnischfeger F; Lu Y; Li Z; Chen YH; Zheng W; Liu W
    J Leukoc Biol; 2015 Aug; 98(2):223-34. PubMed ID: 25979433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
    J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19 regulates B lymphocyte responses to transmembrane signals.
    Fujimoto M; Poe JC; Inaoki M; Tedder TF
    Semin Immunol; 1998 Aug; 10(4):267-77. PubMed ID: 9695183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
    Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
    Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.
    Venkataraman C; Lu PJ; Buhl AM; Chen CS; Cambier JC; Bondada S
    Eur J Immunol; 1998 Oct; 28(10):3003-16. PubMed ID: 9808169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of activatory and inhibitory signals in human B-cells.
    Sármay G; Koncz G; Gergely J
    Immunol Lett; 1996 Dec; 54(2-3):93-100. PubMed ID: 9052860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19, from bench to bedside.
    Li X; Ding Y; Zi M; Sun L; Zhang W; Chen S; Xu Y
    Immunol Lett; 2017 Mar; 183():86-95. PubMed ID: 28153605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCgamma.
    Vigorito E; Kovesdi D; Turner M
    Cell Signal; 2006 Sep; 18(9):1455-60. PubMed ID: 16380231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.
    Inabe K; Kurosaki T
    Blood; 2002 Jan; 99(2):584-9. PubMed ID: 11781242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19 controls Toll-like receptor 9 responses in human B cells.
    Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
    J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification.
    Fujimoto M; Fujimoto Y; Poe JC; Jansen PJ; Lowell CA; DeFranco AL; Tedder TF
    Immunity; 2000 Jul; 13(1):47-57. PubMed ID: 10933394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
    Kitanaka A; Ito C; Coustan-Smith E; Campana D
    J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
    Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
    J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.